Indian Pharma Venus signs marketing deal for their antibiotic with South Korean Goodwills Co helping them to address 15% of the USD 300Mn antibiotic segment
Switzerland based STMicroelectronics looks at India for tapping part of 15-20% growth (in next two years) in Asian medical devices market.
"Indian vaccines are globally competitive. India produces 60 percent of the worlds vaccine and account for about 70 percent of the annual United Nations vaccine purchases.The current Indian vaccine market is estimated at around $900 million"